These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7848483)

  • 41. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
    Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
    J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dipyridamole plus aspirin and hemodialysis graft patency.
    Hentschel DM
    N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176
    [No Abstract]   [Full Text] [Related]  

  • 44. Advanced treatment of acute femoropopliteal bypass graft occlusion with Fogarty catheter guidance.
    Albayrak G; Aykut K; Guzeloglu M; Gulcu A; Hazan E
    Vascular; 2014 Aug; 22(4):262-6. PubMed ID: 23929429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A simple technique to prevent graft kinking during tunneling of a reversed vein femoropopliteal bypass graft.
    Eifell R; Mudawi A
    Surg Today; 2007; 37(4):356-8. PubMed ID: 17387575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
    Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anastomosis angle is a key to improved long-term patency of proximal femoropopliteal bypass.
    Grus T; Lindner J; Vidim T; Tosovsky J; Matecha J; Rohn V; Lambert L; Grusova G
    Ann Vasc Surg; 2009; 23(5):598-605. PubMed ID: 19747610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting.
    Burger DH; Kappetein AP; Van Bockel JH; Breslau PJ
    J Vasc Surg; 2000 Aug; 32(2):278-83. PubMed ID: 10917987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
    Devine C; McCollum C;
    J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 52. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A; Eckstein HH;
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patency rate of small caliber fibrous polyurethane vascular prostheses implanted in the dog carotid and femoral artery improved by use of acetylsalicylic acid and dipyridamol.
    Hess F; Steeghs S; Braun B; van Det R; Grande P; Jerusalem C; Skotnicki S
    Thorac Cardiovasc Surg; 1988 Aug; 36(4):221-6. PubMed ID: 3187983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting.
    Timaran CH; Stevens SL; Grandas OH; Piercy KT; Freeman MB; Goldman MH
    J Vasc Surg; 2000 Sep; 32(3):506-16; 516-8. PubMed ID: 10957657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distal femoropopliteal bypass using a composite graft of PTFE and non-reversed saphenous vein.
    Holdsworth PJ; Riddell PS; Leveson SH
    Ann R Coll Surg Engl; 1989 Jan; 71(1):4-6. PubMed ID: 2923418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dipyridamole plus aspirin and hemodialysis graft patency.
    Weale AR; Cooper DG
    N Engl J Med; 2009 Aug; 361(7):720; author reply 721. PubMed ID: 19675337
    [No Abstract]   [Full Text] [Related]  

  • 59. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
    Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
    J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.